TW201225858A - Array of complementary infant/young child nutritional compositions - Google Patents
Array of complementary infant/young child nutritional compositions Download PDFInfo
- Publication number
- TW201225858A TW201225858A TW100141479A TW100141479A TW201225858A TW 201225858 A TW201225858 A TW 201225858A TW 100141479 A TW100141479 A TW 100141479A TW 100141479 A TW100141479 A TW 100141479A TW 201225858 A TW201225858 A TW 201225858A
- Authority
- TW
- Taiwan
- Prior art keywords
- nutritional
- composition
- compositions
- series
- nutritional compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 179
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 91
- 230000000295 complement effect Effects 0.000 title claims description 11
- 230000009286 beneficial effect Effects 0.000 claims abstract description 41
- 238000000034 method Methods 0.000 claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 claims abstract description 4
- 239000006041 probiotic Substances 0.000 claims description 27
- 235000018291 probiotics Nutrition 0.000 claims description 27
- 230000000968 intestinal effect Effects 0.000 claims description 15
- LWGJTAZLEJHCPA-UHFFFAOYSA-N n-(2-chloroethyl)-n-nitrosomorpholine-4-carboxamide Chemical compound ClCCN(N=O)C(=O)N1CCOCC1 LWGJTAZLEJHCPA-UHFFFAOYSA-N 0.000 claims description 15
- 241000186660 Lactobacillus Species 0.000 claims description 14
- 229940039696 lactobacillus Drugs 0.000 claims description 14
- 235000013343 vitamin Nutrition 0.000 claims description 14
- 239000011782 vitamin Substances 0.000 claims description 14
- 229930003231 vitamin Natural products 0.000 claims description 14
- 229940088594 vitamin Drugs 0.000 claims description 14
- 206010012735 Diarrhoea Diseases 0.000 claims description 13
- 229920001542 oligosaccharide Polymers 0.000 claims description 13
- 150000002482 oligosaccharides Chemical class 0.000 claims description 12
- 235000018102 proteins Nutrition 0.000 claims description 12
- 102000004169 proteins and genes Human genes 0.000 claims description 12
- 108090000623 proteins and genes Proteins 0.000 claims description 12
- 239000003925 fat Substances 0.000 claims description 11
- 235000019197 fats Nutrition 0.000 claims description 11
- 239000002775 capsule Substances 0.000 claims description 10
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 9
- 230000000529 probiotic effect Effects 0.000 claims description 9
- 208000008589 Obesity Diseases 0.000 claims description 8
- 235000020824 obesity Nutrition 0.000 claims description 8
- 206010020751 Hypersensitivity Diseases 0.000 claims description 7
- 230000007815 allergy Effects 0.000 claims description 7
- 208000015181 infectious disease Diseases 0.000 claims description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 7
- 239000011707 mineral Substances 0.000 claims description 7
- 235000010755 mineral Nutrition 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 150000004665 fatty acids Chemical class 0.000 claims description 6
- 230000002265 prevention Effects 0.000 claims description 6
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 5
- 210000000987 immune system Anatomy 0.000 claims description 5
- 235000014655 lactic acid Nutrition 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 5
- 235000013336 milk Nutrition 0.000 claims description 5
- 239000008267 milk Substances 0.000 claims description 5
- 210000004080 milk Anatomy 0.000 claims description 5
- 239000002777 nucleoside Substances 0.000 claims description 5
- 125000003835 nucleoside group Chemical group 0.000 claims description 5
- 239000002773 nucleotide Substances 0.000 claims description 5
- 125000003729 nucleotide group Chemical group 0.000 claims description 5
- 239000000843 powder Substances 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- 239000012141 concentrate Substances 0.000 claims description 4
- 206010012601 diabetes mellitus Diseases 0.000 claims description 4
- 206010020772 Hypertension Diseases 0.000 claims description 3
- 240000001046 Lactobacillus acidophilus Species 0.000 claims description 3
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 claims description 3
- 241001468157 Lactobacillus johnsonii Species 0.000 claims description 3
- 241000186605 Lactobacillus paracasei Species 0.000 claims description 3
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 claims description 3
- 229940039695 lactobacillus acidophilus Drugs 0.000 claims description 3
- 235000015097 nutrients Nutrition 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 229910052709 silver Inorganic materials 0.000 claims description 3
- 239000004332 silver Substances 0.000 claims description 3
- 239000011573 trace mineral Substances 0.000 claims description 3
- 235000013619 trace mineral Nutrition 0.000 claims description 3
- 208000024172 Cardiovascular disease Diseases 0.000 claims description 2
- 206010011469 Crying Diseases 0.000 claims description 2
- 241000186604 Lactobacillus reuteri Species 0.000 claims description 2
- 108010063045 Lactoferrin Proteins 0.000 claims description 2
- 102000010445 Lactoferrin Human genes 0.000 claims description 2
- 229940071604 biogaia Drugs 0.000 claims description 2
- 210000000936 intestine Anatomy 0.000 claims description 2
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 claims description 2
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 2
- 229940078795 lactoferrin Drugs 0.000 claims description 2
- 235000021242 lactoferrin Nutrition 0.000 claims description 2
- 235000012054 meals Nutrition 0.000 claims description 2
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 108060003951 Immunoglobulin Proteins 0.000 claims 2
- 101710191666 Lactadherin Proteins 0.000 claims 2
- 102100039648 Lactadherin Human genes 0.000 claims 2
- 230000003187 abdominal effect Effects 0.000 claims 2
- 230000003930 cognitive ability Effects 0.000 claims 2
- 239000003102 growth factor Substances 0.000 claims 2
- 102000018358 immunoglobulin Human genes 0.000 claims 2
- 241001608472 Bifidobacterium longum Species 0.000 claims 1
- 241000186840 Lactobacillus fermentum Species 0.000 claims 1
- 241000194035 Lactococcus lactis Species 0.000 claims 1
- 102000016943 Muramidase Human genes 0.000 claims 1
- 108010014251 Muramidase Proteins 0.000 claims 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 claims 1
- 235000014897 Streptococcus lactis Nutrition 0.000 claims 1
- 241000194024 Streptococcus salivarius Species 0.000 claims 1
- 206010000059 abdominal discomfort Diseases 0.000 claims 1
- 239000003242 anti bacterial agent Substances 0.000 claims 1
- 229940088710 antibiotic agent Drugs 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 229940009291 bifidobacterium longum Drugs 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 235000019658 bitter taste Nutrition 0.000 claims 1
- 230000003920 cognitive function Effects 0.000 claims 1
- 230000002526 effect on cardiovascular system Effects 0.000 claims 1
- 230000008030 elimination Effects 0.000 claims 1
- 238000003379 elimination reaction Methods 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 208000019622 heart disease Diseases 0.000 claims 1
- 208000026278 immune system disease Diseases 0.000 claims 1
- 229940072221 immunoglobulins Drugs 0.000 claims 1
- 229940012969 lactobacillus fermentum Drugs 0.000 claims 1
- 235000010335 lysozyme Nutrition 0.000 claims 1
- 239000004325 lysozyme Substances 0.000 claims 1
- 229960000274 lysozyme Drugs 0.000 claims 1
- 230000035764 nutrition Effects 0.000 abstract description 6
- 235000012041 food component Nutrition 0.000 abstract description 2
- 235000013350 formula milk Nutrition 0.000 description 28
- 230000008901 benefit Effects 0.000 description 11
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 8
- 230000000694 effects Effects 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 102000004190 Enzymes Human genes 0.000 description 6
- 108090000790 Enzymes Proteins 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 101100194625 Rattus norvegicus Rgs19 gene Proteins 0.000 description 5
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 5
- 150000003722 vitamin derivatives Chemical class 0.000 description 5
- 241000186000 Bifidobacterium Species 0.000 description 4
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 4
- 235000021342 arachidonic acid Nutrition 0.000 description 4
- 229940114079 arachidonic acid Drugs 0.000 description 4
- 230000037208 balanced nutrition Effects 0.000 description 4
- 235000019046 balanced nutrition Nutrition 0.000 description 4
- 230000001332 colony forming effect Effects 0.000 description 4
- 238000000855 fermentation Methods 0.000 description 4
- 230000004151 fermentation Effects 0.000 description 4
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 4
- 150000003271 galactooligosaccharides Chemical class 0.000 description 4
- 230000000813 microbial effect Effects 0.000 description 4
- 239000000758 substrate Substances 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- DVSZKTAMJJTWFG-SKCDLICFSA-N (2e,4e,6e,8e,10e,12e)-docosa-2,4,6,8,10,12-hexaenoic acid Chemical compound CCCCCCCCC\C=C\C=C\C=C\C=C\C=C\C=C\C(O)=O DVSZKTAMJJTWFG-SKCDLICFSA-N 0.000 description 3
- GZJLLYHBALOKEX-UHFFFAOYSA-N 6-Ketone, O18-Me-Ussuriedine Natural products CC=CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O GZJLLYHBALOKEX-UHFFFAOYSA-N 0.000 description 3
- -1 Gaipi Chemical class 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- 230000008133 cognitive development Effects 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- KAUVQQXNCKESLC-UHFFFAOYSA-N docosahexaenoic acid (DHA) Natural products COC(=O)C(C)NOCC1=CC=CC=C1 KAUVQQXNCKESLC-UHFFFAOYSA-N 0.000 description 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 description 3
- 230000007774 longterm Effects 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000194108 Bacillus licheniformis Species 0.000 description 2
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 description 2
- 241000186012 Bifidobacterium breve Species 0.000 description 2
- 241000193403 Clostridium Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 240000002605 Lactobacillus helveticus Species 0.000 description 2
- 235000013967 Lactobacillus helveticus Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 2
- 241000191940 Staphylococcus Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- 244000057717 Streptococcus lactis Species 0.000 description 2
- 102000009618 Transforming Growth Factors Human genes 0.000 description 2
- 108010009583 Transforming Growth Factors Proteins 0.000 description 2
- 239000000370 acceptor Substances 0.000 description 2
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 2
- 229940009289 bifidobacterium lactis Drugs 0.000 description 2
- 210000001072 colon Anatomy 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940090949 docosahexaenoic acid Drugs 0.000 description 2
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 2
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 2
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- RQFCJASXJCIDSX-UUOKFMHZSA-N guanosine 5'-monophosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O RQFCJASXJCIDSX-UUOKFMHZSA-N 0.000 description 2
- 235000013928 guanylic acid Nutrition 0.000 description 2
- 230000007407 health benefit Effects 0.000 description 2
- 210000005027 intestinal barrier Anatomy 0.000 description 2
- 230000007358 intestinal barrier function Effects 0.000 description 2
- 229940054346 lactobacillus helveticus Drugs 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 230000035800 maturation Effects 0.000 description 2
- 238000009629 microbiological culture Methods 0.000 description 2
- 108010071421 milk fat globule Proteins 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000000153 supplemental effect Effects 0.000 description 2
- 235000019871 vegetable fat Nutrition 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- WYYXDSQOPIGZPU-UHFFFAOYSA-N 6-aminohexane-1-thiol Chemical compound NCCCCCCS WYYXDSQOPIGZPU-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241001088532 Alyxia ruscifolia Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000222120 Candida <Saccharomycetales> Species 0.000 description 1
- 241000260546 Carpoglyphus lactis Species 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000194033 Enterococcus Species 0.000 description 1
- 241000194031 Enterococcus faecium Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 102000030902 Galactosyltransferase Human genes 0.000 description 1
- 108060003306 Galactosyltransferase Proteins 0.000 description 1
- 102000051366 Glycosyltransferases Human genes 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 1
- 241001147746 Lactobacillus delbrueckii subsp. lactis Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 241000194036 Lactococcus Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 244000147568 Laurus nobilis Species 0.000 description 1
- 235000017858 Laurus nobilis Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000235395 Mucor Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- OVRNDRQMDRJTHS-BKJPEWSUSA-N N-acetyl-D-hexosamine Chemical compound CC(=O)NC1C(O)O[C@H](CO)C(O)C1O OVRNDRQMDRJTHS-BKJPEWSUSA-N 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108091034117 Oligonucleotide Proteins 0.000 description 1
- 206010033307 Overweight Diseases 0.000 description 1
- 241000192001 Pediococcus Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 241000186429 Propionibacterium Species 0.000 description 1
- 235000019904 Raftiline® Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241000235527 Rhizopus Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 102000003838 Sialyltransferases Human genes 0.000 description 1
- 108090000141 Sialyltransferases Proteins 0.000 description 1
- 108010073771 Soybean Proteins Proteins 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010793 Steam injection (oil industry) Methods 0.000 description 1
- 241000888288 Streptococcus salivarius K12 Species 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 1
- 241000500332 Tetragenococcus halophilus Species 0.000 description 1
- 241000224526 Trichomonas Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N adenyl group Chemical class N1=CN=C2N=CNC2=C1N GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Natural products NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 210000000172 cytosol Anatomy 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 238000007580 dry-mixing Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940032049 enterococcus faecalis Drugs 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 150000002574 ketohexoses Chemical class 0.000 description 1
- JCQLYHFGKNRPGE-FCVZTGTOSA-N lactulose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 JCQLYHFGKNRPGE-FCVZTGTOSA-N 0.000 description 1
- 229960000511 lactulose Drugs 0.000 description 1
- PFCRQPBOOFTZGQ-UHFFFAOYSA-N lactulose keto form Natural products OCC(=O)C(O)C(C(O)CO)OC1OC(CO)C(O)C(O)C1O PFCRQPBOOFTZGQ-UHFFFAOYSA-N 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229940057917 medium chain triglycerides Drugs 0.000 description 1
- 210000004379 membrane Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 230000009450 sialylation Effects 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940001941 soy protein Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000004382 visual function Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/244—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin from corms, tubers or roots, e.g. glucomannan
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/25—Exudates, e.g. gum arabic, gum acacia, gum karaya or tragacanth
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/113—Acidophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/143—Fermentum
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/147—Helveticus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/151—Johnsonii
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/165—Paracasei
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/231—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/245—Salivarius
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/21—Streptococcus, lactococcus
- A23V2400/249—Thermophilus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/519—Breve
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/531—Lactis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/533—Longum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Dispersion Chemistry (AREA)
- Pediatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Description
201225858 六、發明說明: 【發明所屬之技術領域】 本發明係關於嬰兒/幼兒營養之領域。詳言之,本發明 係關於對嬰兒/幼兒具有有益作用之一系列營養組合物。 • 該系列營養組合物包含至少兩種組合物,其在預期有益作 用方面相互補充。本發明另外係關於適用於提供健康益處 之一系列營養組合物。本發明另外係關於包含該系列營養 組合物的用於嬰兒/幼兒之營養套組。本發明另外係關於 製備該系列營養組合物的方法。本發明另外係關於用於嬰 兒/幼兒的投與方案。 【先前技術】 已知針對0至6個月、6個月至1歲及丨歲至2歲的不同年齡 群之嬰兒配方 '較大嬰兒配方(f0ll0w_up f〇rmulae)及成長 乳(growing-up milk)。此等嬰兒配方、較大嬰兒配方及成 長乳目標在於滿足不同年齡之嬰兒/幼兒之需要並向嬰兒/ 幼兒提供平衡營養。 國際專利申請公開案WO 2009/068549中描述用於嬰兒/ 幼兒之依年齡特製的營養系統,其中蛋白質性質及含量適 於特定年齡群。 • 市場上之嬰兒7幼兒營養配方中存在之許多特殊組分意 欲提供一些超出平衡營養之有益作用。舉例而言,已在嬰 兒/幼兒營養配方中包括益生菌以提供一些益處,諸如腸 道成熟、腸道保護及自腸道不適恢復。 此等嬰兒/幼兒營養配方欲提供未必特別針對目標群的 159823.doc 201225858 -些盈處。所提供之益處亦未必解決可能影響較目標群 的更特別狀況。 【發明内容】 本發明之目標 因此需要提供更特別針對特定目標群之嬰兒/幼兒營養 配方且其比此項技術中已知之嬰兒/幼兒營養配方更有效 地提供所定義之預期有益作用。 此目標藉助於巾請專利範圍獨立項來解決1請專利範 圍附屬項進一步擴展本發明之中心思想。 因此在第態、樣中,本發明係關於包含至少兩種組合 物之-系列營養組合物,其中該等組合物各自之組成經選 擇以相互補充,從而提供預期有益作用。 本發明另外係關於如申請專利範圍第i項至第9項中任一 項之彡列營養組合物之用途,其係用於預防或治療腹 4 >預防H療腸道不適、降低以後生活巾肥胖之風險及 如同血壓、糖尿病之相關病症之風險、降低以後生活中過 敏之風險$》以後生活巾的心' ▲管疾病、降低感染風 險確保正常生長曲線、確保免疫系統、腸道障壁之良好 成熟、確保最佳認知發展。 本發明另外係關於用於嬰兒/幼兒的營養套組。營養套 組包含如中請專利冑圍第1項至第9項中任H 一系列營 養。物其中該等營養組合物經包裝為單次劑量單位, 各早位包含復原時足以製備單獨—份食物的營養組合物。 亦描述—種製造對嬰兒/幼兒具有有益作用之一系列營 159823.doc 201225858 δ物的方法。該方法包含以下步驟: 製備至少兩種用於嬰兒/幼兒之營養組合物; 選擇至少一種預期達成有益作用之組分;及 將該至少- #組分與該等營養組合物以使該等組合物在 預期有益作用方面相互補充。 亦揭示種用於嬰兒/幼兒的投與方案。用於嬰兒/幼兒 之投與方案包含以下步驟:將至少兩種營養組合物銀給該 表兒/幼兒,其中該等營養組合物相互補充以對嬰兒/幼兒 具有有益作用》 【實施方式】 為完全瞭解本發明及其優點,參考本發明之以下詳細描 述。 應瞭解當考慮申請專利範圍及以下詳細描述時,本發明 之各種實施例可與本發明之其他實施例組合且僅為作出及 使用本發明之特定方式的例示且不限制本發明之範嘴。 在本發明描述中,當閱讀及解釋描述、實例及申請專利 範圍時應考慮以下字詞定義。 嬰兒:根據關於嬰兒配方及較大嬰兒配方之歐盟委員會 指令2006/141/EC(2006年12月22日),條款2(a),術語「嬰 兒」意謂年齡在12個月以下之兒童。 幼兒:根據關於嬰兒配方及較大嬰兒配方之歐盟委員會 指令2006/14.1/EC(2006年12月22日),條款2(b),術語「幼 兒j意謂年齡在一歲至三歲的兒童。 嬰兒配方:根據關於嬰兒配方及較大嬰兒配方之歐盟委 159823.doc 201225858 員會指令2006/141/EC(2006年12月22日),條款2(c),術語 「嬰兒配方」意謂欲用於在生命的頭幾個月期間之嬰兒的 特定營養用途且在引入適當補充食物之前其本身即可滿足 該等嬰兒之營養需求的食物。必須瞭解可給嬰兒完全银食 嬰兒配方,或護理者可使用嬰兒配方作為母乳之補充。其 為廣泛使用之表述「第一階段配方(starter formula)」的同 義詞。 較大嬰兒配方:根據關於嬰兒配方及較大嬰兒配方之歐 盟委員會指令委員會指示2006年12月22曰之2006/141/EC (2006年.12月22曰)’ 2(d),術語「較大嬰兒配方」意謂欲 用於已引入適當補充食物之嬰兒之特定營養用途且構成該 等嬰兒日益多樣化膳食之主要液態元素的食物。 益生菌:根據論文Probiotics in Man and Animals,J Appl BacteHol· 66: 365-378,益生菌定義為活微生物食物 補充物’其藉由改善主體之腸道微生物平衡來對該主體動 物產生有利影響。 ,本發明係關於包含至少兩種組合物之一系列營養組合 物。形成一系列營養組合物之一部分的營養組合物對嬰兒/ 幼兒具有有益作用。 營養組合物較佳為嬰兒配方或較大嬰兒配方。 在本發明中,營養組合物可呈供用於加水復原之粉末形 式。營養組合物可呈供稀釋之濃縮物形式。在營養組合物 復原或稀釋時’最終產物較佳為液體。 該系列營養組合物之有益作用超出提供平衡營養之益 159823.doc 201225858 處。有益作用可為以下任何一種:預防或治療腹瀉 '預防 或治療腸道不適、減輕由腹瀉造成之不適、降低以後生活 中肥胖(包括肥胖相關病症,例如高血壓、糖尿病)之風 險、降低以後生活中過敏之風險、減少以後生活中之心血 - 管疾病、降低感染風險、確保免疫系統良好成熟、確保腸 道障壁良好成熟、確保最佳認知發展。關於良好成熟,應 瞭解該成熟遵循用母乳餵養婴兒/幼兒時所見之生長曲 線。 形成該系列營養組合物之一部分的組合物經選擇以在預 期有益作用方面相互補充。因此,可達成更特別且更有效 之結果。此意謂經由食用該系列營養組合物達成全部預期 益處。該系列營養組合物之組合物獨立使用時不具有與其 在該系列營養組合物中一起使用所具有之相同作用。因 此,組合物以協同方式起作用且所要效果得以增強且大於 各組合物之個別作用的總和。 所用之組合物通常包含脂肪來源'蛋白f來源及碳水化 合物來源。 選自乳脂及/或植物性脂 高油酸葵花油、高油酸紅 營養組合物中之脂肪來源可 肪。植物性脂肪包括棕櫚油精、 花油、菜籽油、大豆油、魚油、椰子油、來源於真菌之細 胞油或其任何混合物。 碳水化合物來源包括乳糖、嚴糖、麥芽糊精 漿、澱粉及其混合物。 該等組合物可另外包含蛋白f,諸如完整蛋白質或水解 159823.doc 201225858 蛋白質、與乳脂球膜(MFGM)結合之蛋白質、TGF-B(轉化 生長因子)、酪蛋白、乳清蛋白、大豆蛋白、乳鐵傳遞蛋 白或其任何混合物。 所用組合物可包含乳脂球膜(MFGM) <· 此外’組合物可包含選自維生素、礦物質、微量元素、 核苷、核苷酸、益菌助生質及益生菌之組分。 維生素可為維生素A、β-胡蘿蔔素、維生素d、維生素 Ε、維生素Κ1、维生素C、維生素Β1、維生素Β2、菸酸、 維生素Β6、葉酸、泛酸、維生素則2、生物素、膽鹼、肌 醇或其任何混合物。 礦物質可為鈉、鉀 '氣、鈣、磷、鎂、錳或其任何混合 物。 微量元素可為鐵、碘、銅、鋅、硒、氟、鉻、鉬或其任 何混合物。 在該系列營養組合物中,個別組合物彼此之間的差異在 於至少一種組分之性質及/或量不同。 該系列營養組合物之一種組合物與另一組合物中有差異 之組分可為以下任一者:維生素、礦物質、核苷、核苷 西夂、益菌助生質、益生菌、蛋白質、脂肪酸、脂肪來源、 蛋白質來源及碳水化合物來源。 盈菌助生質為-種不易消化的食物成份,其藉由選擇性 地刺激結腸中-種或有限數目之細菌的生長及/或活性而 f利地影響主體,且因此改善主體㈣。該等成份因為在 胃或小腸中不分解及吸收而不易消化且因此完整傳至結 159823.doc 201225858 腸,在結腸中其經有益細菌選擇性地醱酵。益菌助生質之 貫例包括某些养畴,諸如果寡膽(FOS)'阿拉伯膠及半乳 券醣(GOS)。可使用益菌助生質之組合’諸如9〇% g〇s與 ίο%短鏈果募醣(諸如以商標Raftilose⑧銷售之產品)或1〇% 菊糖(諸如以商標Raftiline®銷售之產品)之組合。 特別較佳之益菌助生質為半乳寡醣、N_乙酿化寡膽及唾 液酸化券醣之混合物,其中N·乙醯化寡醣構成寡醣混合物 之0.5 至4.0% '半乳寡酶構成寡聽混合物之92 〇%至 9 8.5 X»且唾液酸化券膽構成寡混合物之1 〇 %至4 〇 %。此 混合物在下文中稱為「CMOS-GOS」。 較佳地,本發明系列之任何組合物含有以乾物質計2 5 重量%至15.0重量%的(:]^〇1(}〇8,其限制條件為組合物 包含至少0.02重1 %之N-乙醯化寡醣、至少2.〇重量%之半 乳寡醣及至少0.04重量%之唾液酸化寡醣。 適合之N-乙醯化募醣包括GalNAcal、祀叫丨扣丨。及
Galpl,6GalNAcal,3Galpl,4Glc。N-乙酿化寡可藉由葡糖 胺酶及/或半乳糖胺酶對N-乙醯基-葡萄糖及/或N-乙醯基半 乳糖之作用來製備。同樣地,N•乙醯基_半乳糖轉移酶及/ 或N-乙醯基-糖基轉移酶可用於此目的。亦可藉由醱酵技 術使用各別秘(重組或天然)及/或微生物酸酵作用來產生N_ 乙醯化寡醣。在後一種情況下,微生物可表現其天然酶及 受質或可經工程改造以產生各別受質及酶。可使用單一微 生物培養物或混合培養物。可由自聚合度(1)1))=1起之任何 DP開始由受體受質起始形成N-乙酿化寡醣。另一選擇為 159823.doc 201225858 將游離或結合至寡醣(例如乳酮糖)之酮基-己醣(例如果糖) 化學轉化成N-乙醯基己醣胺或含有寡醣之N-乙醯基己醣 胺,如 Wrodnigg,T. M.; Stutz,A.E. (1999) Angew. Chem. Int. Ed. 38:827-828 中所述。 適合之半乳寡醣包括 Gaipi,6Gal,Gaipi,6Galpl,4Glc、 Gaipi,6Gaipi,6Glc 、 Gaipi ,3Gaip 1,3Glc 、
Gaipi,3Gaipi,4Glc 、 Gaip 1,6Gaip 1,6Gaip 1,4Glc 、
Gaipi,6Gaipi,3Gaipi,4Glc ' Gaip 1,3Gaip 1,6Gaip 1,4Glc ' Gaipi,3Gaipi,3Gaipi,4Glc 、 Gaip 1,4Gaip 1,4Glc 及
Gaipi,4Galpl,4Gaipi,4Glc。 合成半乳寡醣諸如 Gaipi,6Galpl,4Glc 、 Gaipi,6Gaipi,6Glc 、 Gaip 1,3Gaip 1,4Glc 、
Galpl,6Gaipi,6Galpl,4Glc ' Gal01,6Gaipi,3Gaipi,4Glc 及 Galpl,3Gaipi,6Gaipi,4Glc 、 Gaip 1,4Gaip 1,4Glc 及 〇丑101,4〇&101,4〇&101,4〇1(:及其混合物可以商標¥丨¥丨1^1©及 Elix'or®購得。寡醣之其他供應商為Dextra Laboratories、 Sigma-Aldrich Chemie GmbH及 Kyowa Hakko Kogyo Co·, Ltd。或者,可使用特定糖基轉移酶,諸如半乳糖苷基轉 移酶來產生中性寡醣。 適合之唾液酸化寡_包括NeuAca2,3Galpl,4Glc及 NeuAca2,6Gaipi,4Glc »可藉由詹析或過濾、技術自諸如動 物乳之天然來源分離此等唾液酸化寡醣。或者,其亦可藉 由生物技術使用特定唾液酸轉移酶藉由酶基醱酵技術(重 組或天然酶)或藉由微生物醱酵技術來產生。在後一種情 159823.doc -10- 201225858 況下,微生物可表現其天然酶及受質或可經工程改造以產 生各別受質及酶。可使用單一微生物培養物或混合培養 物。可由自聚合度(DP)=1起之任何DP開始由受體受質起始 形成唾液酸寡醣。 可使用之適合之益生菌微生物之實例包括酵母,諸如酵 母菌屬少、德巴利酵母屬、假 絲酵母屬(CawdWflj、畢赤酵母屬及球擬酵母屬 ;黴菌,諸如曲徽菌屬、酒麴菌 屬(Rhizopus)、毛’数镜屬(Mucor·)反青数菌屬(Penicilliuni) 及球擬酵母屬;及細菌,諸如雙叉桿菌屬 、擬桿菌屬(5acier〇i'c?ej)、梭孢桿菌屬 (C/os/rW/ww)、細梭菌屬(Fwsokcieriww)、蜜蜂球菌屬 (Me/^sococcwi1)、丙酸桿菌屬、鍵球菌 屬(iSVrepiococcM·?)、腸球菌屬(EVzierococcws)、乳球菌屬 (Laciococcws)、葡萄球菌屬、消化鍵球菌 屬、芽孢桿菌屬、小球菌屬 (Pei^cieoccws)、微球菌屬(Mz'crococcws)、白念珠球菌屬 (ZrewcowoWoc)、魏斯氏菌屬(preisse/Za)、氣球菌屬 (jerococcws)、酒球菌屬(Oewococcw·?)及乳桿菌屬 。適合之益生菌微生物之特定實例為:釀 酒酵母(iSaccAizro/njces cereWseae)、凝結芽抱桿菌 、地衣芽抱桿菌(^Sacz·//!/*? /z’cAe«i/ormh)、枯草芽 抱桿箆(Bacillus subtilis)、雙成雙又得蛰(Bifidobacterium 、嬰兒雙叉桿菌沿)、龍根
S 159823.doc 201225858 雙叉桿菌客mtm)、屎腸球菌(A/iie/OCoccMS /aec/t/w)、糞腸球菌(五wierococcM«y /aecfl/z's)、嗜酸乳桿菌 {Lactobacillus i7c/i/〇j?A"M5)、消化乳桿菌(ZracioZ^cW/i/s 、乾酷·乳桿菌乾酷亞種(Zflciofcacz·//!/·? caser· sw办·?/>. cflsei)、乾路乳桿菌代田株(Z/acioZ^acz/Zw*? caw/ 5Αζ>σίύ〇、蠻曲乳桿菌cwrvaiws)、德氏乳桿 菌乳酸亞種(Ζύ^ίο6ύ^ζ·//Μ·5 fi?e/6rwcA:iz· «sw&sp. /acib)、香腸 乳得儀(Lactobacillus farciminus)、加氏乳择儀(Lactobacillus 容flwerz·)、瑞士 乳桿菌Ae/veHcMS)、約氏乳 择窗[Lactobacillus johnsonii)、洛德乳得菌(Lactobacillus reuteri)、I 李糖乳得議(Lactobacillus rhamnosus, Zctcic^ac"/!^ GG)、清酒乳桿菌<saA:e)、乳酸 乳球菌(Zaciococcws /acib)、易變微球菌(A/7c"ococcm*s varians) ' 乳酸小球菌(/Vi//c>cc>ccw5 acidilactici) ' 戊糖小 球菌(尸ei/ioeoccws peniosacews)、乳酸小球菌、嗜鹽小球菌 (Pediococcus halophilus)、嗜液逢珠儀(Streptococcu Sfl/ivflriMS)、糞鍵球菌(《SYre/jiococcMs /aeca//5)、嗜熱鍵球. 镜(Streptococcus thermophilus)、肉菊萄球菌(Staphylococcus car/zosMs)及木糖葡萄球菌(57叩办少/ococcwi1 X少/0SM5)。 較佳益生菌菌株包括可自芬蘭之Valio Oy公司以商標 LGG獲得之鼠李糖乳桿菌ATCC .53 103 ;可自BioGaia AB獲 得之鼠李糖乳桿菌CGMCC 1.3724、副乾酪乳桿菌CNCM 1-2116、洛德乳桿菌ATCC 55730及洛德乳桿菌DSM 17938;尤其由丹麥之Christian Hansen公司以商標Bb 12銷 159823.doc -12- 201225858 售之乳酸雙又桿菌CNCM 1-3446及由日本之Morinaga Milk Industry Co. Ltd·以商標BB536銷售之龍根雙叉桿菌ATCC BAA-999 ;瑞士乳桿菌CNCM 1-4095、龍根雙叉桿菌 CNCM 1-2618、短型雙又桿菌CNCM 1-3 865、乳酸乳球菌 /ac"\s)CNCM 1_4154、副乾酪乳桿菌 33(Uni President)、唾液鏈球菌 K12 ATCC BAA-1024(BLIS)、嗜熱 鏈球菌CNCM 1-3915、約氏乳桿菌CNCM 1-1225、醱酵乳 桿菌 VRI-033 PCC 菌株 NM 02/31074(Probiomix)或來自 Calpis之嗜酸乳桿菌L92菌株FERM BP.4981。 所用之益生菌微生物可為活的或死的益生菌微生物。 益生菌之存在量較佳為103至10〗2菌落形成單位/公克組 合物或毫升組合物、更佳為106至1〇n菌落形成單位/公克 組合物或毫升組合物、甚至更佳為1〇4至1〇9菌落形成單位/ 公克組合物或毫升組合物、最佳為1 〇7至1 〇9菌落形成單位/ 公克組合物或毫升組合物。該系列中一種組合物與另一種 組合物之量可不同。舉例而言,已發現藉由提供包含乳酸’ 雙又桿菌CNCM 1-3446之第一組合物及包含洛德乳桿菌 DSM 17938之第二組合物,該等益生菌之作用持續及增強 之方式不可由唯一益生菌負載來匹配。 組合物可視情況含有可能具有有益作用之其他物質,諸 如核苷酸、核苷及其類似物。核苷酸可選自胞嘧啶核苷單 填酸(CMP)、尿㈣核料_(UMp)、腺嗓吟核皆單碟 酸(AMP)、鳥嘌呤核苷單磷酸(GMp)或其任何混合物。 任何營養組合物均可包含脂肪酸,諸如中鏈甘油三酯及/ 159823.doc
S -13- 201225858 或長鏈多不飽和脂肪酸(LC-PUFA)。脂肪酸有益於嬰兒/幼 兒發育。較佳地,LC-PUFA係選自二十二碳六稀酸 (DHA)、二十碳四烯酸(ARA)、十二碳五烯酸(EPA)或其任 何混合物。在本發明之一實施例+,系列組备物可包含第 一組合物’其包含二十二碳六烯酸(DHA)與二十碳四缔酸 (ARA)之混合物作為脂肪酸,而第二組合物僅包含二十二 碳六烯酸(DHA)。當用第一組合物餵養12個月至24個月之 時期’隨後用第二組合物餵養至少6個月之時期時,觀測 到與嬰兒/幼兒腦發育有關之長期益處。 有益作用可為本文中所描述之任何作用且其超過平衡營 養之有益作用。 舉例而言’該系列組合物可預期用於減輕由腹瀉造成之 不適。因此,第一組合物可包含幫助治療腹瀉之組分。此 組分可為益生菌,例如鼠李糖乳桿菌CGMCC 1.3724。第 二組合物包含治療腹瀉之後腸道不適的另一組分。此可為 洛德乳桿菌DSM 17938。因此,該等組合物在減輕由腹瀉 造成之不適的預期有益作用方面相互補充。 舉例而s ’本發明之系列組合物可用於促進斷乳。因 此’第一組合物可包含乳酸雙叉桿菌CNCM 1-3446,而第 二組合物可包含副乾酪乳桿菌33(Uni President)。該等組 合物之組合對嬰兒/幼兒更平穩地斷乳具有整體有益作 用。作為指示,發現用本發明系列餵養之嬰兒相較於用傳 統嬰兒配方傲養之嬰兒在開始斷乳時啼哭頻率較低。 或者,一種組合物與另一種組合物中脂肪酸類型可不 159823.doc -14- 201225858 同。舉例而言,一種組合物可包含適當比率之DHA及 ARA,而另一種可能僅包含DHA。此等組合物組合時提供 健康益處,諸如腦及視覺功能之健康發育及健康免疫發 育。 該系列營養組合物可包含相同組分但至少一種組分之量 不同。舉例而言,一種組合物與另一種組合物之脂肪含量 可不同。因此’本發明系列可包含第一組合物,其包含 5.〇公克脂肪/1〇〇千卡至6公克脂肪/1〇〇千卡,及第二組合 物,其包含3公克脂肪/100千卡至5公克脂肪/1〇〇千卡。當 將各組合物在6個月至1年之時期内餵給幼兒,尤其年齡分 別為1歲至2歲及2歲以上之幼兒時,所觀測到之益處為相 較於用傳統組合㈣養之嬰兒,以後生活中肥胖之風險及 超重之傾向有所降低。 形成本發明系列之-部分的組合物可餵給嬰兒/幼兒持 續1天至12個月之時期。此時期可根據預期有益作用而變 匕舉例而5 想減輕由腹渴造成之不冑,則言亥系列之 :且合物可⑽天至5天之時期。作為另一實例,若想要長 』有益作用,則該時期可為!個月至12個月,較佳為約_ 本發明系列之特徵為組合物中存在之元素 成特定益處。 用以3 實際上,已發現藉由用包含乳酸雙又桿菌之營養組 餵給嬰兒’隨後用與前述組合物差異僅在於另外包含 乳桿菌的營養組合M — 1嬰兒可獲得有益作用 159823.doc 201225858 該有益作用相較於僅用一種組合物餵養嬰兒有所增強。 在本發明之一實施例中,該系列包含兩種組合物。在另 貫施例中,該系列包含二種組合物。在又一實施例中, 該組合包含四種組合物。 該系列之組合物可預期用於特定年齡群。舉例而言,組 合物可預期用於0至6個月、6個月至丨歲、丨歲至2歲之嬰兒 或用於年齡大於2歲之幼兒。 在本發明之系列中,組合物可用於相同年齡群,或者, 其可用於兩個或兩個以上連續年齡群。 ―本文中所描述之系列可根據本發明用於預防或治療腹 瀉、預防或治療腸道不適、減輕由腹瀉造成之不適、降低 以後生活中肥胖(及相關病症,如高血壓及糖尿病)之風 險、降低以後生活中過敏之風險、減少以後生活中的心血 管疾病、降低感染風險、確保正常生長曲線、確保免疫系 統良好成熟、確保腸道障壁良好成熟及確保最佳認知發 展。 本發明另外係關於用於嬰兒/幼兒的營養套組。該營養 套組包含如上所述之該系列營養組合。各營養組合物經包 裝為單次劑量單位。各單次劑量單位中之營養組合物含量 足以在用水復原時製成單獨一份食物。 單獨一份食物一般包含8公克至35公克,較佳1〇公克至 3〇公克,最佳11公克至28公克的粉末,供添加8〇毫升至 3〇〇毫升之水復原。較佳為9〇毫升及250毫升之水。或者, 若營養組合物為濃縮物,則單獨一份食物包括1毫升至5〇 159823.doc •16- 201225858 毫升的濃縮物,供添加50毫升至250毫升之水稀釋β 該套組包含如本文中所描述之該系列營養組合物。單次 劑量單位可呈膠囊之形式。單次劑量單位亦可呈棒狀包裝 或藥囊之形式。膠囊可為裝備有含於膠囊内之開口構件的 拋棄式膠囊,以允許將配方直接自膠囊送出至諸如瓶之接 收容器中。此類使用膠囊來分配嬰兒或幼兒營養組合物之 方法描述於國際專利申請公開案第W〇 2006/077259號中。 形成該系列營養組合物之一部分的營養組合物因此可包裝 於個別膠囊中且呈多件包裝形式提供給消費者。多件包裝 可例如含有足以滿足嬰兒一週之需要的膠囊數目β適合之 膠囊構造揭示於國際專利申請公開案第W〇 2003/059778號 中。 本發明亦係關於一種製造對嬰兒/幼兒具有有益作用之 該系列營養組合物的方法。 該方法之第一步驟在於製備至少兩種用於嬰兒/幼兒之 營養組备物。 營養組合物可依任何適合之方式製備。舉例而言,可藉 由將蛋白質來源、碳水化合物來源及脂肪來源依適當比例 摻合在一起形成摻合物,來製備嬰兒/幼兒組合物。摻合 物中可包括乳化劑。維生素及礦物質可在此時添加,但通 常稍後添加以避免熱降解。在摻合之前可將任何親脂性維 生素、乳化劑及其類似物溶於脂肪來源中。隨後可將水 (較佳為已經過逆滲透之水)混合於其中,形成液體混合 物。 159823.doc -17- 201225858 隨後可加熱處理液體混合物,以減少細菌負荷。舉例而 §,可將液體混合物快速加熱至約至約丨丨〇。〇範圍内 之溫度下,並持續約5秒至約5分鐘。此舉可藉由蒸汽喷射 或由熱交換器(例如板式熱交換器)來進行。隨後可例如藉 由急驟冷卻將液體混合物冷卻至約6(rc至約85<>c❶隨後可 將液體混合物例如分兩個階段均質化,第一階段在約? Μρ& 至約40 MPa下且第一階段在約2 MPa至約14 MPa下。隨後 可將經均質化之混合物進一步冷卻,以便添加任何熱敏性 組分,諸如維生素及礦物質。此時宜使經均質化之混合物 的PH值及固體含量標準化。將經均質化之混合物轉移至適 合之乾燥設備(諸如噴霧乾燥機或冷凍乾燥機)中並轉化成 粉末。該粉末所具有之水分含量應小於約3重量%。或 者’將經均質化之混合物濃縮。 該方法之第二步驟為選擇至少一種預期達成有益作用之 組分》 &瞭解該至^種組分本身無法革獨達成預期有益作 用:貫際上’本發明依靠至少兩種組合物之互補來達成該 有皿作用。因此,選擇該組分係出於其能夠以補充方式幫 助提供所需之有益作用。 ^方法另外包含以下步驟:將至少一種組分與該等營養 組合物之至少一者組合,以使該等組合物相互補充以達成 預期有益作用。 β藉由乾式混合法將組分添加至粉末狀嬰兒配方中。或 者’可在營養組合物製備過程早期添加該組分。熟習技術 159823.doc 201225858 者能夠確定應在何時將所選擇之組分併入至營養組合物 中。 用於嬰兒/幼兒之投與方案亦為本發明之一部分。該投 與方案提供對嬰兒/幼兒之益處。投與方案包括以下步 驟.將一系列至少兩種營養組合物餵給嬰兒/幼兒。如所 提及,該營養組合物相互補充,以對該嬰兒/幼兒具有有 益作用。 兩種纽合物可在同一個餵養階段餵給。或者,用其中一 種組合物餵養嬰兒/幼兒1天至12個月之時期,且用另一種 組合物餵養嬰兒/幼兒1天至12個月之時期。 營養組合物可作為營養之唯一來源餵給或可作為膳食之 一部分,例如用於斷乳嬰兒/幼兒。較佳地,餵給嬰兒/幼 兒之組合物涵蓋嬰兒/幼兒之膳食之一半以上。 已如此詳細地描述本發明及其優點,應瞭解該詳細描述 不欲限制本發明之範疇。 欲由專利特許證所保護之内容在以下申請專利範圍中闡 述欲由專利特許證保護之内容。 159823.doc -19-
Claims (1)
- 201225858 -tr、申請專利範圍: 1. 一種一系列營養組合物,其包含至少兩種組合物,其中 該等組合物各自之組成經選擇以相互補充,從而提供預 期有益作用。 2. 如請求項1之一系列營養組合物,其中該至少兩種組合 物彼此之間的差異在於至少一種組分之性質及/或含量不 « 同。 3. 如請求項2之一系列營養組合物,其中該至少一種組分 為以下任一者:維生素、礦物質、微量元素、核苷、核 苷酸、益菌助生質、益生菌、乳鐵傳遞蛋白、脂肪酸、 脂肪、碳水化合物、蛋白質、生長因子、免疫球蛋白、 MFGM組分、寡膽。 4. 如請求項3之一系列營養組合物,其中該等益生菌係選 自可自芬蘭之Valio Oy公司以商標LGG獲得之鼠李糖乳 桿議(Lactobacillus rhamnosus)ATCC 53 103 ;可自 BioGaia AB獲得之鼠李糖乳桿菌CGMCC 1,3724、副乾酪 乳桿菌paracaseOCNCM 1-2116、洛德乳 桿菌rewier〇ATCC 55730 及洛德乳桿菌 , DSM 17938 ;尤其由丹麥之Christian Hansen公司以商標 . Bb 12銷售之乳酸雙又样菌/ach’dCNCM 1-3446及由日本之 Mori naga Milk Industry Co. Ltd.以商標 BB536銷.售之龍根雙.又桿菌 longum)ATCC BAA-999 i -±r % # ^ {Lactobacillus /ze/vei/cwi)CNCM 1-4095、龍根雙又桿菌 CNCM 1-2618、 159823.doc 201225858 短型雙叉桿菌6reve)CNCM 1-3865、乳 酸乳球菌(Zacococcws /aci/*s)CNCM 1-4154、副乾酷乳桿 / 菌 33(Uni President)、唾液鏈球菌(《SVrepiococcws salivarius)K\2 ATCC BAA-1024(BLIS) ' 嗜熱鏈球菌 («SVrepiococcM·? i/2ermo/?/n7wj)CNCM 1-3915、約氏乳桿菌 (Ζ^£^σ6π///Μ·5 yo/znsow/QCNCM 1-1225、礙酵乳桿菌 {Lactobacillus fermentum)WRl-033 PCC 菌株 NM 02/31074(Probiomix)或來自Calpis之嗜酸乳桿菌 (Lacio厶菌株 FERM BP.4981 〇 5. 如請求項3之一系列營養組合物,其中該等益生菌可為 死的或活的益生菌或其任何混合物。 6. 如前述請求項中任一項之一系列營養組合物,其中該等 營養組合物係呈粉末或濃縮物形式。 7 ·如前述請来項中任一項之一系列營養組合物,其中該有 益作用為以下任一者:預防或治療腹瀉、預防或治療腸 道不適、減輕由腹瀉造成之不適、降低以後生活中肥胖 及相關之高血壓及糖尿病之風險、降低以後生活中過敏 之風險、減少以後生活中的心▲管疾病、降低感染風 險、確保正常生長曲線、確保免疫系統、腸道障壁及認 知功能的良好成熟。 8. 如前述請求項中任一項之一系列營養組合物,其中第一 組合物預期治療腹瀉且第二組合物預期治療腹瀉之後的 腸道不適。 9. 如前述請求項中任一項之一系列營養組合物,其中第一 I59823.doc -2- 201225858 組合物預期有利於消除與投與抗生素有關之腸道不適或 疼痛且第二組合物預期在投與抗生素之後恢復天然腸道 菌群。 1 〇·如别述請求項中任一項之一系列營養組合物其中第一 組合物預期改善睡眠模式且第二組合物預期促使嬰兒產 生主動學習能力。 11. 12. 一種如前述請求項中任一項之一系列營養組合物的用 途,其係用於預防或治療腹填、預防或治療腸道不適、 減輕由腹瀉造成之不適、降低以後生活中肥胖之風險、 降低以後生活中過敏之風險、減少以後生活中之心血管 確保正常生長曲線、確保免疫系 疾病、降低感染風險、 統良好成熟、減少職、減少錢、改善睡眠模式、減 少啼哭時間、減少腸道不適、改善學習能力、刺激認知 能力或其組合。 -種用於嬰兒/幼兒之營養套組,其包含如請求項⑴❻ 中任-項之-系列營養組合物’其中該等營養組合物經 包裝為單次劑量單位,各單次劑量單位包含足以製備單 獨一份食物的營養組合物》 其中該等單次 13.如請求項12之用於嬰兒/幼兒之營養套組, 劑量單位為膠囊。 14. 一種用於製造對嬰兒/幼兒具有有益作用之一 合物的方法’其包括以下步驟: 製備至少兩種用於嬰兒/幼兒之營養組合物 選擇至少一種預期達成該有益作用之組分 系列營養組 :及 159823.doc 201225858 將該至少-種組分與該營養組合物之至少一4 以使該等組合物在該預期有益作用方面相互補充。 15.::求項14之方法,其中預期達成該有益作用 分係選自維生素、礦物質、核苦、核普酸、益菌助生 質1生m酸1肪、碳水化合物、蛋白質、生 長因子、免疫球蛋白、MFGM組分、寡醣、溶菌酶。 16·如請求項14或15之方法,其中該等有益作用為以下任-者:預防或治療«、預防或治療腸道不適、減輕由腹 腐造成之不適、降低以後生活中肥胖之風險、降低以後 生活中過敏之風險、減少以後生活中之心血管疾病、降 低感染風險、確保正常生長曲線、確保免疫系統良好成 a、減少過敏、減少感染、改善睡眠模式、減少啼突時 間、減少腸道不適、改善學習能力、刺激認知能力或其 組合。 Π. 一種用於嬰兒/幼兒之投與方案,其包括以下步驟:银給 如請求項1至10中任一項之一系列至少兩種營養組合 物。 18. 如請求項17之方案,#中用第―營養組合物㈣該嬰兒/ 幼兒1天至12個月之時期,隨後用第二營養組合物假養1 天至12個月之時期。 19. 如請求項17及18中任-項之方案,其中銀給該嬰兒/幼兒 之該兩種營養組合物涵蓋該嬰兒/幼兒之膳食的一半以 159823.doc 201225858 四、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: 五、本案若有化學式時,請揭示最能顯示發明特徵的化學式: (無) 159823.doc -2·
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10191199A EP2452571A1 (en) | 2010-11-15 | 2010-11-15 | Array of complementary infant/young child nutritional compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
TW201225858A true TW201225858A (en) | 2012-07-01 |
Family
ID=43530412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW100141479A TW201225858A (en) | 2010-11-15 | 2011-11-14 | Array of complementary infant/young child nutritional compositions |
Country Status (13)
Country | Link |
---|---|
US (2) | US20130280239A1 (zh) |
EP (2) | EP2452571A1 (zh) |
CN (1) | CN103209601A (zh) |
AU (1) | AU2011331411A1 (zh) |
BR (1) | BR112013011624A2 (zh) |
CA (1) | CA2817128A1 (zh) |
CL (1) | CL2013001387A1 (zh) |
IL (1) | IL225813A0 (zh) |
MX (1) | MX2013005362A (zh) |
RU (1) | RU2013127306A (zh) |
SG (1) | SG189520A1 (zh) |
TW (1) | TW201225858A (zh) |
WO (1) | WO2012065812A1 (zh) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101166798B1 (ko) * | 2011-12-19 | 2012-07-26 | 김대현 | 락토바실러스 애시도필러스 엘비의 사균을 포함하는 알레르기 질환의 치료 또는 예방용 의약 조성물 |
US11179427B2 (en) | 2013-01-21 | 2021-11-23 | Eth Zurich | Baby food composition comprising viable propionic acid-producing bacteria |
WO2015086170A1 (en) * | 2013-12-12 | 2015-06-18 | Nestec S.A. | Synthetic milk compositions for optimal growth and development and prevention of obesity in male and female infant and children |
EP3124031B1 (en) * | 2014-03-25 | 2020-12-30 | Kabushiki Kaisha Yakult Honsha | Sleep quality improver |
CN104206539A (zh) * | 2014-08-14 | 2014-12-17 | 澳优乳业(中国)有限公司 | 一种益生菌婴幼儿奶粉 |
EP3294308A4 (en) | 2015-05-14 | 2019-03-06 | University of Puerto Rico | PROCESS FOR RECOVERING THE BIOZOOSE OF NEWBORN |
US11564667B2 (en) | 2015-12-28 | 2023-01-31 | New York University | Device and method of restoring microbiota of newborns |
CN108495562A (zh) * | 2016-01-26 | 2018-09-04 | 雀巢产品技术援助有限公司 | 具有特异性低聚糖的用于预防或治疗变态反应的组合物 |
WO2017129649A1 (en) * | 2016-01-26 | 2017-08-03 | Nestec S.A. | Compositions with specific oligosaccharides to prevent later in life obesity or related comorbidities, by increasing colonic scfa production and/or by increasing glp-1 secretion |
IT201600131819A1 (it) * | 2016-12-28 | 2018-06-28 | Metis Healthcare S R L | Preparazione per spray orale |
BR112019028039A2 (pt) | 2017-06-30 | 2020-07-07 | N.V. Nutricia | composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hiperinsulinemia |
BR112019028006A2 (pt) * | 2017-06-30 | 2020-07-07 | N.V. Nutricia | composição nutricional, uso de uma combinação de bifidobacterium breve e oligossacarídeos não digeríveis, e método para prevenir e/ou reduzir o risco de ocorrência de hipercolesterolemia e/ou aterosclerose |
WO2020161113A1 (en) * | 2019-02-04 | 2020-08-13 | N.V. Nutricia | Fermented formula with non digestible oligosaccharides for sleep improvement |
CN111840522B (zh) * | 2019-04-26 | 2023-10-20 | 武汉禾元生物科技股份有限公司 | 一种利用重组蛋白治疗儿童感染性腹泻的口服复方制剂 |
CN116855413B (zh) * | 2023-07-07 | 2024-02-09 | 镇江远森医药科技有限公司 | 利用鼠李糖乳杆菌YSs069制备调节人体微生态平衡的生物活性物质及其应用 |
CN117159702A (zh) * | 2023-09-19 | 2023-12-05 | 广州见华医学科技有限公司 | 一种乳铁蛋白胶囊在调节人体免疫力的用途 |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1062873A1 (en) * | 1999-12-13 | 2000-12-27 | N.V. Nutricia | Improved infant formula, protein hydrolysate for use in such an infant formula, and method for producing such a hydrolysate |
US6592863B2 (en) * | 2000-08-22 | 2003-07-15 | Nestec S.A. | Nutritional composition |
EP3121134B1 (en) | 2002-01-16 | 2021-11-03 | Société des Produits Nestlé S.A. | Closed capsule with opening mean |
EP1597978A1 (en) * | 2004-05-17 | 2005-11-23 | Nutricia N.V. | Synergism of GOS and polyfructose |
US7862808B2 (en) * | 2004-07-01 | 2011-01-04 | Mead Johnson Nutrition Company | Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12 |
ES2259885B1 (es) * | 2004-09-29 | 2007-11-01 | Laboratorios Ordesa, S.L. | Kit nutricional infantil para regular el ciclo de sueño-vigilia. |
MX2007008895A (es) | 2005-01-24 | 2008-01-28 | Nestec Sa | Metodo para preparar una composicion nutricional. |
EP1714660A1 (en) * | 2005-04-21 | 2006-10-25 | N.V. Nutricia | Uronic acid and probiotics |
US7572474B2 (en) * | 2005-06-01 | 2009-08-11 | Mead Johnson Nutrition Company | Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
WO2008054192A1 (en) * | 2006-11-02 | 2008-05-08 | N.V. Nutricia | Use of nutritional compositions for preventing disorders |
MY149913A (en) * | 2006-03-07 | 2013-10-31 | Nestec Sa | Synbiotic mixture |
WO2007140613A1 (en) * | 2006-06-06 | 2007-12-13 | Mcgill University | Fermented milk product and use thereof |
US20080003329A1 (en) * | 2006-06-30 | 2008-01-03 | Ricardo Rueda | Enriched infant formulas |
NL1033521C2 (nl) * | 2007-03-08 | 2008-09-09 | Friesland Brands Bv | Kindervoedingen met geoptimaliseerde aminozuursamenstelling. |
CL2008001595A1 (es) * | 2007-05-30 | 2009-09-25 | Nestec Sa | Kit de composiciones nutricionales para niños de 6 a 36 meses, una composicion comprende 44-46% de energia de grasa y 47-49% de energia de carbohidratos para niños de 6-8 meses, otra, 39-41% de energia de grasa y 49-52% de energia de carbohidratos para niños de 8-12 meses y otra, 34-35% de energia de grasa y 51-53% energia de carbohidratos para niños de 12-36 meses; y uso del kit. |
US9402412B2 (en) * | 2007-05-30 | 2016-08-02 | Nestec S.A. | Metabolic imprinting |
MY160434A (en) | 2007-11-26 | 2017-03-15 | Nestec Sa | Age-tailored nutrition system for infants |
MX2010008028A (es) * | 2008-01-24 | 2010-09-07 | Nestec Sa | Capsula que contiene ingredientes nutritivos y metodo de suministro de un liquido nutritivo desde la capsula. |
EP3682874A1 (en) * | 2008-09-02 | 2020-07-22 | N.V. Nutricia | Nutritional compositions with coated lipid globules |
CA2745234A1 (en) * | 2008-12-05 | 2010-06-10 | Nestec S.A. | Compositions for use in low-birth weight infants |
-
2010
- 2010-11-15 EP EP10191199A patent/EP2452571A1/en not_active Withdrawn
-
2011
- 2011-10-25 EP EP11779602.9A patent/EP2640202A1/en not_active Withdrawn
- 2011-10-25 WO PCT/EP2011/068610 patent/WO2012065812A1/en active Application Filing
- 2011-10-25 AU AU2011331411A patent/AU2011331411A1/en not_active Abandoned
- 2011-10-25 CA CA2817128A patent/CA2817128A1/en not_active Abandoned
- 2011-10-25 CN CN2011800548773A patent/CN103209601A/zh active Pending
- 2011-10-25 MX MX2013005362A patent/MX2013005362A/es unknown
- 2011-10-25 RU RU2013127306/13A patent/RU2013127306A/ru not_active Application Discontinuation
- 2011-10-25 SG SG2013031372A patent/SG189520A1/en unknown
- 2011-10-25 BR BRBR112013011624-2A patent/BR112013011624A2/pt not_active IP Right Cessation
- 2011-10-25 US US13/885,619 patent/US20130280239A1/en not_active Abandoned
- 2011-11-14 TW TW100141479A patent/TW201225858A/zh unknown
-
2013
- 2013-04-17 IL IL225813A patent/IL225813A0/en unknown
- 2013-05-15 CL CL2013001387A patent/CL2013001387A1/es unknown
-
2015
- 2015-03-17 US US14/659,846 patent/US20150181916A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2817128A1 (en) | 2012-05-24 |
EP2640202A1 (en) | 2013-09-25 |
US20150181916A1 (en) | 2015-07-02 |
AU2011331411A2 (en) | 2014-07-17 |
CL2013001387A1 (es) | 2014-03-14 |
MX2013005362A (es) | 2013-06-28 |
AU2011331411A1 (en) | 2013-05-23 |
SG189520A1 (en) | 2013-06-28 |
WO2012065812A1 (en) | 2012-05-24 |
IL225813A0 (en) | 2013-07-31 |
BR112013011624A2 (pt) | 2015-09-01 |
CN103209601A (zh) | 2013-07-17 |
EP2452571A1 (en) | 2012-05-16 |
US20130280239A1 (en) | 2013-10-24 |
RU2013127306A (ru) | 2014-12-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201225858A (en) | Array of complementary infant/young child nutritional compositions | |
RU2570473C2 (ru) | Комплект питательных смесей с пробиотиками, созданных с учетом возраста | |
AU2020201932A1 (en) | Infant formula system with adaptive levels of human milk oligosaccharides (HMOs) | |
TW201242518A (en) | Oligosaccharide mixture and food product comprising this mixture, especially infant formula | |
AU2009224732B2 (en) | Medium chain dicarboxylic acids, their derivates and metabolic disorders | |
TW201233334A (en) | Human milk oligosaccharides to promote growth of beneficial bacteria | |
TW201004574A (en) | A nutritional composition with free amino acids and structured lipids | |
CN114522175A (zh) | 用于预防或治疗婴儿和幼儿的坏死性小肠结肠炎的组合物 | |
TW201002216A (en) | Probiotics to improve gut microbiota | |
TW200936147A (en) | Prevention and treatment of secondary infections following viral infection | |
TW201117818A (en) | Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients | |
TW201100537A (en) | Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles | |
JP2011504365A (ja) | 乳児のための年齢に合わせた栄養システム | |
TW201223457A (en) | Age-tailored nutritional formula with particularly adapted caloric density for young infants | |
TW201223458A (en) | Age-tailored nutritional formula with particularly adapted caloric density for infants and children | |
WO2016026684A1 (en) | Prebiotics for reducing the risk of obesity later in life | |
TW201225857A (en) | Age-tailored nutritional composition with animal fats and vegetable fats | |
TW201208582A (en) | Array of age-tailored nutritional formula with optimum fat content | |
TW201105252A (en) | Prevention and treatment of allergic diarrhoea | |
CN114745966A (zh) | 用于减少婴儿和幼儿的疼痛和/或疼痛感的组合物 | |
AU2014361228A1 (en) | Array of age-tailored nutritional formulae with optimum mineral nutrient content | |
Shirsath et al. | Role of Food Supplements in Gut Health | |
TW201130429A (en) | Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof | |
TW201304695A (zh) | 一系列依年齡特製之含有益生菌之營養配方 | |
Facts | Probiotics and Prebiotics |